January 9, 2025

In January 2025, Alverno Laboratories announced important updates regarding specimen requirements and testing procedures by Quest Diagnostics. For Myoglobin, Urine, effective December 23, 2024, specimens must now be submitted in specialized myoglobin urine transport tubes, available through the Supply Request Form on AlvernoLabs.com. For Soluble Transferrin Receptor, plasma collected in EDTA (lavender-top) tubes will no longer be accepted; instead, serum in SST tubes or plasma in sodium/lithium heparin (green-top) tubes must be used. Additionally, as of January 13, 2025, Quest Diagnostics will discontinue individual anti-fungal susceptibility tests for yeast, recommending a comprehensive yeast susceptibility panel as the alternative. For more details, including test codes and ordering information, visit AlvernoLabs.com.